In human plasma samples, decreased choline and choline metabolites were seen in T2DM/obese IR patients compared to obese insulin sensitive individuals, indicating that higher choline and metabolites may confer decreased risk of MetS/IR [74]. The gene discussed is INS; the disease is type 2 diabetes mellitus.